Ep #39 More Than Just Flakes: Seborrheic Dermatitis, Dandruff, and the FDA-Approved Treatment Changing Everything

Is dandruff really just dry skin? Not quite.In this episode, Dr. Sandy Skotnicki and Marlo Sutton break down the science behind seborrheic dermatitis—a common but often misunderstood inflammatory condition that causes persistent scalp and facial flaking, redness, and irritation.This episode is sponsored by Arcutis, developer of targeted dermatology therapies such as roflumilast.Listeners will learn:Why seborrheic dermatitis is more than dandruff—it’s driven by oil production, yeast (Malassezia), and inflammationWhat it actually looks like across different skin typesWhy traditional treatments like antifungal shampoos and steroids don’t always provide lasting controlThe emerging issue of antifungal resistanceHow roflumilast (a topical PDE-4 inhibitor) works differently by targeting inflammation, not just yeastWhat the clinical trials show, including fast results and strong long-term outcomesWhy this new approach may represent a shift in how we treat chronic scalp conditionsThe takeaway? Seborrheic dermatitis is a chronic condition—but with newer treatments targeting inflammation, long-term control is becoming more achievable than ever.Every Thursday on Skin to It, dermatologist Dr. Sandy Skotnicki and beauty enthusiast Marlo Sutton guide you through the maze of skincare, cutting through the noise to help you achieve your healthiest skin. Subscribe to ensure you never miss out on our skincare wisdom!Love our podcast? Tell us what you love about the show to help others discover it too, by sharing your review.Skin to It is a skincare podcast brought to you by Bioderma.For more information about Skin to It, visit skintoitpodcast.com.Follow us on social media at Dr. Sandy Skotnicki and Marlo Sutton.